The NEXT-1 (Next generation pErsonalized tX with mulTi-omics and preclinical model) trial: prospective molecular screening trial of metastatic solid cancer patients, a feasibility analysis-Reference-Cited by-同舟云学术

The NEXT-1 (Next generation pErsonalized tX with mulTi-omics and preclinical model) trial: prospective molecular screening trial of metastatic solid cancer patients, a feasibility analysis

Published:2015-09-09 Issue:32 Volume:6 Page:33358-33368
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Kim Seung Tae¹,Lee Jeeyun¹,Hong Mineui²³,Park Kyunghee⁴⁵,Park Joon Oh¹,Ahn Tae Jin³⁴,Park Se Hoon¹,Park Young Suk¹,Lim Ho Yeong¹,Sun Jong-Mu¹,Ahn Jin Seok¹,Ahn Myung-Ju¹,Kim Hee Cheol⁶,Sohn Tae Sung⁶,Choi Dong Il⁷,Cho Jong Ho⁸,Heo Jin Seok⁶,Kwon Wooil⁶,Uhm Sang Won⁹,Lee Hyuk¹⁰,Min Byung-Hoon¹⁰,Hong Sung No¹⁰,Kim Duk Hwan⁵¹¹,Jung Sin Ho¹²,Park Woongyang⁴⁵,Kim Kyoung-Mee²³,Kang Won Ki¹,Park Keunchil¹²

Affiliation:

1. Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

2. Innovative Cancer Medicine Institute, Samsung Cancer Center, Samsung Medical Center, Seoul, Korea

3. Department of Pathology & Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

4. Samsung Genome Institute, Seoul, Korea

5. Samsung Biological Research Institute, Seoul, Korea

6. Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

7. Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

8. Department of Thoracic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

9. Division of Pulmonology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

10. Division of Gastroenterology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

11. Medical Translational Research Center, Samsung Biological Research Institute, Seoul, Korea

12. Biostatistics and Clinical Epidemiology, Samsung Medical Center, Seoul, Korea

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Analyses of Targeted Myeloid Cancer Next-Generation Sequencing Panel in Fresh Blood, Bone Marrow and FFPE Material;International Journal of Molecular Sciences;2024-03-21

2. Применение панелей комплексного молекулярного профилирования при опухолях желудочно-кишечного тракта. Обзор литературы и собственные результаты;Malignant tumours;2023-11-22

3. TARGET National: A UK-wide Liquid-based Molecular Profiling Programme;Clinical Oncology;2023-01

4. Molecular Profiling–Based Precision Medicine in Cancer: A Review of Current Evidence and Challenges;Frontiers in Oncology;2020-10-27

5. Targeted Therapy Recommendations for Therapy Refractory Solid Tumors—Data from the Real-World Precision Medicine Platform MONDTI;Journal of Personalized Medicine;2020-10-23